Abstract: A sealing arrangement used to create a seal between a first part of a chain and a second part of the chain, wherein the second part can at least be pivoted in relation to the first part, includes a sealing ring with an annular sealing lip for sealing a lubricant area between parts which can be pivoted towards each other, and an elastic ring which is adapted to be fixed to one of the parts and which is adapted to exert pressure in the sealing ring. In addition, a supporting ring is arranged between the sealing ring and the elastic ring.

Abstract: A sealing arrangement used to create a seal between a first part of a chain and a second part of the chain, wherein the second part can at least be pivoted in relation to the first part, includes a sealing ring with an annular sealing lip for sealing a lubricant area between parts which can be pivoted towards each other, and an elastic ring which is adapted to be fixed to one of the parts and which is adapted to exert pressure in the sealing ring. In addition, a supporting ring is arranged between the sealing ring and the elastic ring.

Abstract: A sealing arrangement used to create a seal between a first (12) part of a chain and a second (14) part of a chain, wherein said second part can at least be pivoted in relation to the first part, exhibiting the following features: a sealing ring (40) with an annular sealing lip (42) for sealing a lubricant area between parts which can be pivoted towards each other, an elastic ring (60) which can be fixed to one of the parts and which can be used to exert pressure on the sealing ring; in addition to a supporting ring (50) which is arranged between the sealing ring and the elastic ring; and link of a chain provided with said sealing arrangement.

Abstract: In order to determine the intraoperative risk of bleeding preoperatively, both the content of fibrin monomer (FM) and the partial thromboplastin time (PTT) are determined in a blood or plasma sample.

Abstract: The invention relates to a method for determining a factor XIII deficiency, a method for determining a fibrinogen deficiency, and a method for differentiating between a factor XIII deficiency and a fibrinogen deficiency by means of thrombelastographic techniques. On the basis of the evaluation of the thrombelastographic parameters, a rapid and a selective substitution of factor XIII and/or of fibrinogen in deficiency states is possible.

Abstract: The invention relates to a method for determining a factor XIII deficiency, a method for determining a fibrinogen deficiency, and a method for differentiating between a factor XIII deficiency and a fibrinogen deficiency by means of thrombelastographic techniques. On the basis of the evaluation of the thrombelastographic parameters, a rapid and a selective substitution of factor XIII and/or of fibrinogen in deficiency states is possible.

Abstract: The present invention relates to an in vitro diagnostic method for patients with suspected deep venous thrombosis wherein by combined testing of patients' samples for D-dimer and CRP both the sensitivity and the negative predictive value of DVT diagnostics can be increased up to 100%.

Abstract: A sealing arrangement-used to create a seal between a first (12) part of a chain and a second (14) part of a chain, wherein said second part can at least be pivoted in relation to the first part, exhibiting the following features: a sealing ring (40) with an annular sealing lip (42) for sealing a lubricant area between parts which can be pivoted towards each other, an elastic ring (60) which can be fixed to one of the parts and which can be used to exert pressure on the sealing ring; in addition to a supporting ring (50) which is arranged between the sealing ring and the elastic ring; and link of a chain provided with said sealing arrangement.

Abstract: The present invention relates to an in vitro diagnostic method for patients with suspected deep venous thrombosis wherein by combined testing of patients' samples for D-dimer and CRP both the sensitivity and the negative predictive value of DVT diagnostics can be increased up to 100%.